Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours Β· Estimated delivery Aug 10 - Aug 15
Clinical trial data from the SURMOUNT-1 study showed that up to 29% of participants on tirzepatide for weight loss experienced nausea, primarily during dose escalation phases
Mounjaro is marketed by Lilly USA, LLC, Indianapolis, IN 46285, USA
Learn more: Starting 6/18, the public may submit comments on these applications on regulations.gov to docket number FDA-2025-N-0835
TRIUMPH-1 highlights the importance of options and the potential for retatrutide to help people across various stages of their obesity journey, said Kenneth Custer, executive vice president and president, Lilly Cardiometabolic Health
PMID: 21989665
These injections work best when combined with healthy lifestyle habits such as balanced nutrition and regular exercise
US$ 27.94
US$ 20.46
US$ 21.41
US$ 25.98
US$ 23.94
